Research & Development: Page 86

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaTrax

    Sales, Marketing, and R&D Trends from Industry Lipitor Perceived as Market Leader Among Statin Brands When it comes to statins, the most frequently discussed issue in the blogosphere and general online world is the negative side effects. This is one of the findings in a recent report fielded ...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    UpFront

    Online update SURF’s UP According to Manhattan Research’s latest study, physician site traffic is spread among product sites of new and early-launch stage treatments, those with clinical news coverage, and, consistent with years past, products with a significant consumer advertising component. “W...

    By PharmaVoice Team • Jan. 2, 2008
  • digital pill Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Artificial intelligence & machine learning

    After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Table of Contents

    Table of Contents September 2007 On the Cover Success Beyond the Silos Innovative pharmaceutical companies are redefining the communications process by tearing down the walls between the different factions: agencies, sales, marketing, and public relations. FEATURES Postmarketing Safety in the Spo...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    HIV Market: Stability in Motion

    By Denise Myshko In response to several challenges, the focus of biotech and pharmaceutical development in HIV has shifted to novel classes. HIV is a retrovirus that is constantly adapting and evolving. Rates of drug-related resistance are on the rise and not all antiretroviral agents work for al...

    By Denise Myshko • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    On the Calendar

    Industry Events September 2007 On the Calendar September 16-18 3rd Annual Growth Innovation and Leadership 2007 Hyatt Regency Monterey, Monterey, Calif. For more information, contact Melina Trevino, Frost & Sullivan, at 210-247-2440, e-mail [email protected], or visit frost.com. Septem...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    E-Media

    PharmaLinx Launches Industry Web Portal Professionals who operate in the pharmaceutical, biotechnology, and medical-device sectors, as well as those who provide services and tools to the industry, now have a single source to find targeted information related to their fields. The new portal, Acces...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    DIA 2007 -- Annual Conference

    DIA Addresses extreme topics The 43rd Annual Meeting of the Drug Information Association DIA 2007 — Annual Conference The Drug Information Association’s 43rd annual meeting featured 450 sessions and more than 1,000 speakers. Industry Thought Leaders Raise their VOICE at DIA Podcasts BBK Worldwide...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    7 Rules for New War Games

    Stan Bernard of Bernard Associates says practicing competitive simulations is a better approach than war games because simulations address more of the challenges that companies face. Traditionally, businesses have engaged in war games, in which marketing groups or brand teams compete by dividing ...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    A Born Leader -- Ethan Leder

    By Kim Ribbink Ethan Leder has made a career out of establishing companies in niche markets. Now he is applying the skills he’s learned to evidence-based solutions specialist United BioSource Corp. With an entrepreneurial spirit and intense work ethic, Ethan D. Leder has made a career out of esta...

    By Kim Ribbink • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    The pharmaceutical industry can no longer afford to be off-message — not even just once — in an exceedingly competitive marketplace. Silo busting continues to be a resounding theme in all areas of the industry, it’s a way to improve business processes, increase efficiencies, and stay on message. ...

    By Taren Grom • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    Throughout his career, Joseph Bolen, Ph.D., has been involved in unraveling the mysteries of drug discovery. Now in his positions as Senior VP of Research and Drug Discovery, a role in which he heads all biological research and related functions as well as all drug-discovery functions, and as Chi...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Strengthening the Value of Live CME: Cutting-Edge Strategies to Engage Learners and Extend Reach

    VIEW on Medical Education August 2007 Strengthening the Value of Live CME: Cutting-Edge Strategies to Engage Learners and Extend Reach Sarah Mooney, Director, Strategic Planning & Development Innovia Education Institute LLC In 2006, more than 2 million physicians and healthcare pr...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Transforming U.S. Healthcare Quality Using CME

    Transforming U.S. Healthcare Quality Using CME VIEW on Medical Education August 2007 cme2 Cathy Pagano, Executive Director John Marlow, Chief Medical Officer We believe the mission of all CME needs to be elevated to a whole new level to be clinically meaningful. Looking ahead, a new model...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The True Value of Educational Outcomes Measurement

    VIEW on Medical Education August 2007 The True Value of Educational Outcomes Measurement Sherri Foster, Senior VP and General Manager Outcomes measurement has become the buzzword in continuing medical education (CME) over the past few years. It comes amid growing recognition among stak...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    A Process Map for Maximizing the Impact of Promotional Medical Education

    A Process Map for Maximizing the Impact of Promotional Medical Education Neil Matheson CEO Axis Healthcare Communications LLC CME Planning The goal of all medical education programs is to improve patient care. This goal can be achieved if the participants in the program recognize and...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Emerging Psychographic Segmentation Strategies for Developing Customized Professional Education

    Emerging Psychographic Segmentation Strategies for Developing Customized Professional Education David St. Peter, M.D. President VIEW on Medical Education August 2007 Why Customization Is Important Physicians are people too, and just like everyone else, they have innate differences th...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Table of Contents

    Letter from the Editor The Forum Medical Education: The State of CME — Continuing medical education could be argued to be one of the most ever-changing fundamentals in the healthcare industry today. Ensuring that CME remains in compliance with the latest guidelines and technologies is an ongoing ...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    Old School, New School Taren Grom We look forward to discussing the latest industry trends at the Annual Conference on CME Provider/Industry Collaboration, Oct. 17-19. Please stop by to say hello. Letter from the Editor VIEW on Medical Education August 2007 In September 2006, ...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Making Partnerships Work for Your Educational Programs

    Making Partnerships Work for Your Educational Programs VIEW on Medical Education August 2007 Susan Grady, Chief Medical Director Haleh Kadkhoda, VP of Educational Programs Making the decision to collaborate on an educational initiative is not an easy one. Broach the subject with your team...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    No Crystal Ball Required: The Future of CME Is Already Here

    No Crystal Ball Required: The Future of CME Is Already Here August 2007 VIEW on Medical Education E-CME Niki Oquist, M.D., FAAP, Senior VP, Medical Affairs Advances in technology are changing the way groups and individuals communicate with and amongst one another, and CME providers must embr...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Cover

    PharmaVOICE 100 of the Most Inspiring People July/August 2007 Download PDF

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Postmarketing Safety in the Spotlight

    Improving prescription drug safety and oversight have taken center stage both within Congress and with regulatory authorities. Postmarketing research is an important element of commercialization that enables companies to expand existing markets, enter new markets, develop and deliver messaging th...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Success Beyond the Silos

    By Robin Robinson Forum Innovative pharmaceutical companies are redefining the communications process by tearing down the walls between the different factions: agencies, sales, marketing, and public relations. More and more pharmaceutical companies are breaking out of their siloed structure to re...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Marketplace

    Featured Product and Service Showcases AmerisourceBergen Specialty Group Axis Healthcare Communications LLC Cadent Medical Communications The Center for Biomedical Continuing Education CME LLC cme2 The Curry Rockefeller Group LLC Excerpta Medica Innovia Education Institute LLC Institu...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The State of CME

    August 2007 VIEW on Medical Education The State of CME by Kate Guerriero Continuing medical education could be argued to be one of the most ever-changing fundamentals in the healthcare industry today. Ensuring that CME remains in compliance ...

    By PharmaVoice Team • Jan. 2, 2008